Log In
BCIQ
Print this Print this
 

ApoVax-104

  Manage Alerts
Collapse Summary General Information
Company ApoVax Inc.
DescriptionVaccine against tumor antigen E7, a protein from the human papillomavirus (HPV)
Molecular Target E7 transforming protein (Human papillomavirus-16) (HpV16gp2)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsPrevent cervical cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today